ipilimumab, pembrolizumab, durvalumab, idarubicin, bevacizumab Clinical Trials
2 recruitingDrug
Phase 22
Showing 1–2 of 2 trials
Recruiting
Phase 2
Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.
SurgeryLung CancerNon-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University90 enrolled1 locationNCT06492421
Recruiting
Phase 2
Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.
SurgeryHepatic Cancer
Second Affiliated Hospital of Guangzhou Medical University90 enrolled1 locationNCT06492408